Randomized Controlled Trial of Lactobacillus Casei Strain Shirota Fermented Milk for Alleviating Hard Stools in Vietnam - Trial NCT05982743
Access comprehensive clinical trial information for NCT05982743 through Pure Global AI's free database. This phase not specified trial is sponsored by Yakult Honsha Co., LTD and is currently Completed. The study focuses on Constipation. Target enrollment is 51 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Yakult Honsha Co., LTD
Timeline & Enrollment
N/A
May 11, 2022
Mar 08, 2023
Primary Outcome
Proportion of subjects that produce hard or lumpy stools (Bristol stool form scale (BS) score of 1 or 2) ≥ 25% of bowel movements
Summary
The objective of this study is to provide evidence supporting the efficacy of fermented milk
 containing Lactobacillus casei strain Shirota in alleviating hard or lumpy stools. A
 randomized, controlled trial has been designed on constipated adults with a high prevalence
 of hard stools in Vietnam.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05982743
Non-Device Trial